Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age

Cecilie Utke Rank,Benjamin Ole Wolthers,Kathrine Grell,Birgitte Klug Albertsen,Thomas Leth Frandsen,Ulrik M. Overgaard,Nina Toft,Ove Juul Nielsen,Peder Skov Wehner,Arja Harila-Saari,Mats Heyman,Johan Malmros,Jonas Abrahamsson,Ulrika Norén-Nyström,Beata Tomaszewska-Toporska,Bendik Lund,Kirsten Brunsvig Jarvis,Petter Quist-Paulsen,Goda Vaitkevičienė,Laimonas Griskevicius,Mervi Taskinen,Ulla Wartiovaara-Kautto,Kristi Lepik,Mari Punab,Olafur G. Jonsson,Kjeld Schmiegelow

Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age

2019

PURPOSEAsparaginase-associated pancreatitis (AAP) is common in patients with acute lymphoblastic leukemia (ALL), but risk differences across age groups both in relation to first-time AAP and after ...

Keywords:

Lymphoblastic Leukemia
Pancreatitis
age groups
Internal medicine
Pathology
Gastroenterology
Asparaginase
Medicine
in patient
Young adult
Standard Risk
Erwinia asparaginase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations